Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The New Mexico Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center plays a significant role in facilitating the transfer and utilization of intellectual property rights for collaborative research and commercialization purposes. This agreement enables both parties to safeguard their interests and establish a mutually beneficial relationship in the field of biomedical research and innovation. Keywords: New Mexico Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property rights, collaborative research, commercialization, biomedical research, innovation. There may be different types of New Mexico Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center based on the specific research projects or areas of focus. Some possible types include: 1. Biomedical Research Collateral License Agreement: This agreement could be specifically tailored for the funding, development, and commercialization of biomedical research projects, discoveries, or technologies jointly undertaken by Gentling, Inc. and The University of North Texas Health Science Center. 2. Clinical Trial Collateral License Agreement: This type of agreement may be designed to govern the collaboration between Gentling, Inc. and The University of North Texas Health Science Center in conducting clinical trials for evaluating the safety and efficacy of investigational drugs or medical devices. 3. Technology Transfer Collateral License Agreement: This agreement may establish the terms and conditions for the transfer of proprietary technologies, inventions, or patents from The University of North Texas Health Science Center to Gentling, Inc., allowing the latter to further develop, market, and commercialize these innovations. 4. Data Sharing Collateral License Agreement: In cases where both parties may need to exchange confidential or proprietary data for research or regulatory purposes, a data sharing agreement could be established to protect the privacy and ensure proper usage of the shared information. These are just a few hypothetical examples, and the actual types of New Mexico Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary based on their specific collaborative endeavors and research goals.
The New Mexico Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center plays a significant role in facilitating the transfer and utilization of intellectual property rights for collaborative research and commercialization purposes. This agreement enables both parties to safeguard their interests and establish a mutually beneficial relationship in the field of biomedical research and innovation. Keywords: New Mexico Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, intellectual property rights, collaborative research, commercialization, biomedical research, innovation. There may be different types of New Mexico Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center based on the specific research projects or areas of focus. Some possible types include: 1. Biomedical Research Collateral License Agreement: This agreement could be specifically tailored for the funding, development, and commercialization of biomedical research projects, discoveries, or technologies jointly undertaken by Gentling, Inc. and The University of North Texas Health Science Center. 2. Clinical Trial Collateral License Agreement: This type of agreement may be designed to govern the collaboration between Gentling, Inc. and The University of North Texas Health Science Center in conducting clinical trials for evaluating the safety and efficacy of investigational drugs or medical devices. 3. Technology Transfer Collateral License Agreement: This agreement may establish the terms and conditions for the transfer of proprietary technologies, inventions, or patents from The University of North Texas Health Science Center to Gentling, Inc., allowing the latter to further develop, market, and commercialize these innovations. 4. Data Sharing Collateral License Agreement: In cases where both parties may need to exchange confidential or proprietary data for research or regulatory purposes, a data sharing agreement could be established to protect the privacy and ensure proper usage of the shared information. These are just a few hypothetical examples, and the actual types of New Mexico Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary based on their specific collaborative endeavors and research goals.